Patient Outcomes Transcatheter Aortic Valve Replacement

Excellent Safety Profile

Survival

1.7% Mortality

Low Pacemaker Rates

10% New Permanent Pacemaker

Disabling Stroke

1.7% Disabling Stroke

Low PVL Rates

0.0% Moderate or Severe PVL

Low PVL Rates1

Evolut™ PRO 30-day outcomes

EvolutPRO 30day PVL

Unsurpassed Hemodynamics1

Evolut PRO valve performance
1

Forrest, et al., ACC, 2017
Evolut PRO Clinical Study, 60 patients, 30-day outcomes.